文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人体皮肤利什曼病治疗失败、复发和慢性患者的主要危险因素和组织病理学特征:治疗结果的前瞻性病例对照研究及其医学重要性。

Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.

机构信息

Leishmaniasis Research Center, Kerman Univeprsity of Medical Sciences, Kerman, Iran.

Department of Pathology, Afzalipour Hospital, Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

PLoS Negl Trop Dis. 2021 Jan 28;15(1):e0009089. doi: 10.1371/journal.pntd.0009089. eCollection 2021 Jan.


DOI:10.1371/journal.pntd.0009089
PMID:33507940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7872302/
Abstract

Over the last years, there has been a remarkable increase in the number of unresponsive patients with anthroponotic cutaneous leishmaniasis (ACL) reported worldwide. The primary objective of this study was to explore the role of demographic, clinical and environmental risk related-factors in the development of treatment failure, relapse and chronic cases compared to responsive patients with ACL. Moreover, molecular, histopathological and immunohistochemical (IHC) findings between these forms were explored. This work was undertaken as a prospective and case-control study in southeastern Iran. Culture media and nested PCR were used to identify the causative agent. Univariate multinomial and multiple multinomial logistic regression models and the backward elimination stepwise method were applied to analyze the data. A P<0.05 was defined as significant. Also, for different groups, skin punch biopsies were used to study the histopathological and immunohistochemical (IHC) profile. All samples showed that L. tropica was the only etiological agent in all unresponsive and responsive patients with ACL. Data analysis represented that 8 major risk factors including nationality, age groups, occupation, marital status, history of chronic diseases, duration of the lesion, the lesion on face and presence of domestic animals in the house were significantly associated with the induction of unresponsive forms. The histopathological and immunohistochemical findings were different from one form to another. The present findings clearly demonstrated a positive relation between ACL and distinct demographic, clinical and environmental risk determinants. Knowledge of the main risk factors for ACL infection is crucial in improving clinical and public health strategies and monitor such perplexing factors.

摘要

在过去的几年中,全球范围内报告的无反应性人类皮肤利什曼病(ACL)患者数量显著增加。本研究的主要目的是探讨与人口统计学、临床和环境风险相关因素在治疗失败、复发和慢性病例中的作用,与有反应性 ACL 患者相比。此外,还探讨了这些形式之间的分子、组织病理学和免疫组织化学(IHC)发现。这项工作是在伊朗东南部进行的前瞻性病例对照研究。使用培养介质和巢式 PCR 来鉴定病原体。应用单变量多项和多项多项逻辑回归模型以及向后消除逐步法来分析数据。P<0.05 被定义为显著。此外,对于不同的组,皮肤打孔活检用于研究组织病理学和免疫组织化学(IHC)图谱。所有样本均表明,L. tropica 是所有无反应性和有反应性 ACL 患者的唯一病因。数据分析表明,8 个主要危险因素,包括国籍、年龄组、职业、婚姻状况、慢性病史、病变持续时间、面部病变和家中是否有家畜,与无反应性的发生显著相关。组织病理学和免疫组织化学发现形式之间存在差异。目前的研究结果清楚地表明 ACL 与不同的人口统计学、临床和环境风险决定因素之间存在正相关。了解 ACL 感染的主要危险因素对于改善临床和公共卫生策略以及监测这些复杂因素至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/c49af3864ebf/pntd.0009089.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/dce9beb60f5d/pntd.0009089.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/ecca936ac9db/pntd.0009089.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/487b34878bc6/pntd.0009089.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/3a153a3f57f6/pntd.0009089.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/15d621e0edd0/pntd.0009089.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/c49af3864ebf/pntd.0009089.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/dce9beb60f5d/pntd.0009089.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/ecca936ac9db/pntd.0009089.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/487b34878bc6/pntd.0009089.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/3a153a3f57f6/pntd.0009089.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/15d621e0edd0/pntd.0009089.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/c49af3864ebf/pntd.0009089.g006.jpg

相似文献

[1]
Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.

PLoS Negl Trop Dis. 2021-1

[2]
Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.

PLoS One. 2018-2-7

[3]
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.

PLoS Negl Trop Dis. 2019-6-12

[4]
Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.

Int Immunopharmacol. 2019-2-14

[5]
Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.

Microb Pathog. 2018-11-3

[6]
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.

Trop Med Int Health. 2018-5-21

[7]
A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor.

Parasit Vectors. 2021-2-24

[8]
Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: Clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis.

Transbound Emerg Dis. 2019-4-15

[9]
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.

Microb Pathog. 2018-12-21

[10]
Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran.

Int J Parasitol Drugs Drug Resist. 2023-4

引用本文的文献

[1]
An inclusive assessment of apoptosis mechanisms in species: A narrative literature review.

Curr Res Parasitol Vector Borne Dis. 2025-4-17

[2]
Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis.

Transbound Emerg Dis. 2023-8-26

[3]
Unlocking Responsive and Unresponsive Signatures: A Transfer Learning Approach for Automated Classification in Cutaneous Leishmaniasis Lesions.

Transbound Emerg Dis. 2025-1-21

[4]
The developing role of NRF2 and HMOX1 in treatment response of cutaneous leishmaniasis.

Sci Rep. 2025-4-29

[5]
Preparation, Characterization, and Leishmanicidal Assessment of Silver- and Dapsone-Loaded Niosomes Co-administration: and Study.

Adv Pharm Bull. 2024-12-30

[6]
Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis.

J Epidemiol Glob Health. 2024-3

[7]
Geographical and climatic risk factors of cutaneous leishmaniasis in the hyper-endemic focus of Bam County in southeast Iran.

Front Public Health. 2023

[8]
Systematic Review of Treatment Failure and Clinical Relapses in Leishmaniasis from a Multifactorial Perspective: Clinical Aspects, Factors Associated with the Parasite and Host.

Trop Med Infect Dis. 2023-8-29

[9]
Histological findings associated with treatment response in cutaneous leishmaniasis: a clinicopathological correlation study.

Int J Dermatol. 2023-10

[10]
Healing effects of autologous platelet gel and growth factors on cutaneous leishmaniasis wounds in addition to antimony; a self-controlled clinical trial with randomized lesion assignment.

BMC Res Notes. 2023-9-9

本文引用的文献

[1]
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.

PLoS Negl Trop Dis. 2019-6-12

[2]
Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates.

PLoS Negl Trop Dis. 2019-2-25

[3]
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.

Microb Pathog. 2018-12-21

[4]
Leishmaniasis recidivans by Leishmania tropica in Central Rift Valley Region in Kenya.

Int J Infect Dis. 2018-7-11

[5]
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.

Trop Med Int Health. 2018-5-21

[6]
Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.

PLoS One. 2018-2-7

[7]
Leishmania tropica isolates from non-healed and healed patients in Iran: A molecular typing and phylogenetic analysis.

Microb Pathog. 2018-1-17

[8]
Clinical Features of Anthroponotic Cutaneous Leishmaniasis in a Major Focus, Southeastern Iran, 1994-2014.

Iran J Parasitol. 2017

[9]
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.

PLoS Negl Trop Dis. 2017-12-14

[10]
A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates.

PLoS Negl Trop Dis. 2017-8-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索